Press "Enter" to skip to content

Imagin Medical (CSE-IME; OTC-IMEXF) — Updated Company Profile — July, 2020

Chris Temple 0

Though shares of this medical device research/development company remain down somewhat from my first recommendation to Members, I have recently explained to them why Imagin is not only worth sticking with, but doubling down on.

My complete, updated report on the company can be accessed or downloaded below:

Comments are closed.